Cegedim Stock

Cegedim EBIT

The EBIT of Cegedim (ALCGM.PA) as of Aug 9, 2026 is 30.24 M EUR. In the previous year, EBIT was 11.09 M EUR — a change of 172.77% (higher).

EBIT

30.24 MEUR

YoY

172.77%

Last updated:

In 2026, Cegedim's EBIT was 30.24 M EUR, a 172.77% increase from the 11.09 M EUR EBIT recorded in the previous year.

The Cegedim EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2021
43.69 base
Jan 1, 2022
26.49 base
Jan 1, 2023
18.37 base
Jan 1, 2024
11.09 base
Jan 1, 2025
30.24 base
Jan 1, 2026 (e)
33.01 base
Jan 1, 2027 (e)
34.05 base
Jan 1, 2028 (e)
35.14 base
YEAREBIT (M EUR)
2028 est 35.14
2027 est 34.05
2026 est 33.01
2025 30.24
2024 11.09
2023 18.37
2022 26.49
2021 43.69
2020 21.82
2019 48.45
2018 14.42
2017 18.55
2016 2.95
2015 41.40
2014 38.49
2013 25.59
2012 -34.77
2011 75.92
2010 -7.59
2009 99.83
2008 90.16
2007 89.89
2006 66.20
Access this data via the Eulerpool API

Cegedim Revenue

Cegedim Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
524.71 M EUR
43.69 M EUR
26.22 M EUR
Jan 1, 2022
555.21 M EUR
26.49 M EUR
13.62 M EUR
Jan 1, 2023
616.00 M EUR
18.37 M EUR
-7.41 M EUR
Jan 1, 2024
654.50 M EUR
11.09 M EUR
-14.71 M EUR
Jan 1, 2025
649.17 M EUR
30.24 M EUR
9.40 M EUR
Jan 1, 2026 (e)
659.55 M EUR
33.01 M EUR
29.74 M EUR
Jan 1, 2027 (e)
684.05 M EUR
34.05 M EUR
36.48 M EUR
Jan 1, 2028 (e)
703.00 M EUR
35.14 M EUR
33.18 M EUR

Cegedim Margins

Cegedim stock margins

The Cegedim margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cegedim. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cegedim.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
94.91 %
8.33 %
5.00 %
Jan 1, 2022
95.22 %
4.77 %
2.45 %
Jan 1, 2023
41.50 %
2.98 %
-1.20 %
Jan 1, 2024
95.48 %
1.69 %
-2.25 %
Jan 1, 2025
20.78 %
4.66 %
1.45 %
Jan 1, 2026 (e)
20.78 %
5.00 %
4.51 %
Jan 1, 2027 (e)
20.78 %
4.98 %
5.33 %
Jan 1, 2028 (e)
20.78 %
5.00 %
4.72 %

Cegedim Stock analysis

What does Cegedim do? Cegedim SA is a French company that was founded in 1969. It has since become one of the leading providers of IT solutions for the healthcare industry worldwide. Headquartered in Boulogne-Billancourt, France, the company operates in over 80 countries and employs over 4,000 employees. The business model of Cegedim is focused on improving the efficiency and effectiveness of healthcare providers. To do this, the company offers a wide range of products and services based on IT solutions and digital technologies. These are designed to help doctors, pharmacists, hospitals, insurance companies, and other stakeholders in the healthcare industry improve their workflows and optimize patient care. One of the company's key divisions is the Cegedim Health Data Division, which specializes in the collection, analysis, and processing of health data. This includes databases and analyses of medication prescriptions and medical care pathways. This information provides valuable insights into the market and helps healthcare providers identify trends. In addition, Cegedim offers a wide range of IT solutions for the healthcare industry, including e-health platforms, medical practice software, electronic patient records, and insurance billing systems. One of Cegedim's particular strengths is its experience in data analysis. The company has a broad expertise and years of experience in this field. An example of this is the Cegedim IRIS Index, which enables healthcare providers to assess the effectiveness of their medical care. This tool provides cost-optimized and patient-centered analysis and is, therefore, an important part of the Cegedim product line. Cegedim also works closely with health authorities, hospitals, universities, and other stakeholders to develop innovative ideas and solutions. The company is a member of numerous industry organizations, including the European Health Telematics Association (EHTEL) and the Healthcare Information and Management Systems Society (HIMSS). Cegedim's product range is diverse to meet the different needs of healthcare providers. These include: - PMD, a medical practice software that enables efficient management of practice processes and patient data. - Mobile Health Solutions, which allows doctors and nurses to access patient data and medical information from mobile devices. - Medication Insights, a tool for analyzing medication prescriptions that provides valuable insights into the market for healthcare providers and pharmaceutical companies. Cegedim also relies on strategic partnerships to improve the reach and performance of its products and services. One example of this is the partnership with Salesforce, which leads to the development of joint solutions to support doctors and other healthcare professionals. Overall, Cegedim has established itself as one of the leading companies in the healthcare industry, leveraging innovative technologies and data analysis to help its customers work more effectively and efficiently. Cegedim is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Cegedim's EBIT

Cegedim's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cegedim's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cegedim's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cegedim’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cegedim stock

EBIT of Cegedim is 30.24 M EUR in 2026.

EBIT of Cegedim changed from 11.09 M EUR to 30.24 M EUR, representing a 172.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Cegedim since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Cegedim historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Cegedim

All Key Metrics — Cegedim